The emerging role of E3 ubiquitin ligases and deubiquitinases in metabolic dysfunction-associated steatotic liver disease

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide, with a prevalence as high as 32.4%. MASLD encompasses a spectrum of liver pathologies, ranging from steatosis to metabolic dysfunction-associated steatohepatitis (MASH), fibr...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yu Zhang, Jiahui Yang, Jiali Min, Shan Huang, Yuchen Li, Shanshan Liu
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-03-01
Col·lecció:	Journal of Translational Medicine
Matèries:	E3 ubiquitin ligases Deubiquitinases MASLD MASH Therapeutics
Accés en línia:	https://doi.org/10.1186/s12967-025-06255-2
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!